Omid Hamid, MD - Tracing the Arc of Immunotherapy in Melanoma: Insights on the Current Role and Cutting-Edge Uses of Checkpoint Inhibitors for Patient Care
Tracing the Arc of Immunotherapy in Melanoma: Insights on the Current Role and Cutting-Edge Uses of Checkpoint Inhibitors for Patient Care (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - July 18, 2018 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Economic Outcome Analysis for BRAF Melanoma Anti-CD4+PD-1, & Anti-PD-1 both followed by BRAF-MEK
Ahmad Tarhini, MD, PhD, Cleveland Clinic Main Campus, shares Economic Outcome Analysis for BRAF Melanoma Anti-CD4+PD-1, & Anti-PD-1 both followed by BRAF-MEK at ASCO 2018
Author: Annual-Meeting
Added: 06/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 6, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy: Bridging Knowledge from Melanoma
Dr James Larkin, Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust discusses "Immunotherapy: Bridging Knowledge from Melanoma" from a Kidney Cancer point of view at the 13th Eur...
Author: kidneycancer
Added: 04/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 28, 2018 Category: Cancer & Oncology Source Type: podcasts
USPSTF Recommendation: Behavioral Counseling to Prevent Skin Cancer
Interview with John W Epling, MD, MSEd, Task Force member and co-author of Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - March 20, 2018 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Neurologic Syndrome in Cuban Diplomats, Behavioral Counseling to Prevent Skin Cancer, Hip-Hop Music Videos to Prevent Diabetes, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the March 20, 2018 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - March 20, 2018 Category: General Medicine Authors: JAMA Network Source Type: podcasts
USPSTF Recommendation: Behavioral Counseling to Prevent Skin Cancer
Interview with John W Epling, MD, MSEd, author of Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - March 20, 2018 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Neurologic Syndrome in Cuban Diplomats, Behavioral Counseling to Prevent Skin Cancer, Hip-Hop Music Videos to Prevent Diabetes, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the March 20, 2018 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - March 20, 2018 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
Dr. Hamid On Metastatic Melanoma IDO Inhibitors can help overcome resistance
Ashkan Lashkari, MD, shares Dr. Hamid On Metastatic Melanoma IDO Inhibitors can help overcome resistance at the 2018 Oncology Summit in Huntington Beach, CA <br /><br />Go to: <a target='_blank' href='http://www.moasc.org'>http://www.moasc.org...</a> for more in...
Author: moasc
Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts
238 Trial - Nivolumab as Standard for Melanoma Therapeutics Available for Relapsed Immunotherapy
Omid Hamid MD <br />Chief, Translational Research/Immuno-Oncology<br />Director explains, 238 Trial - Nivolumab as Standard for Melanoma Therapeutics Available for Relapsed Immunotherapy at the 2018 Oncolog...
Author: moasc
Added: 03/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 9, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy in Melanoma: Whats up next?
Omid Hamid MD <br />Chief, Translational Research/Immuno-Oncology<br />Director presents, Immunotherapy in Melanoma at the 2018 Oncology Summit in Huntington Beach, CA <br /><br />Go to: <a target='_blank' href='http://www.moasc.org'>http://www.moasc.org...</a> for more...
Author: moasc
Added: 03/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 6, 2018 Category: Cancer & Oncology Source Type: podcasts
Lower-Dose Combo Immunotherapy Promising for Advanced Melanoma
Dr Jeffrey S. Weber reviews data from an open-label phase 1/2 trial assessing the efficacy and safety of combination pembrolizumab and reduced-dose ipilimumab in patients with advanced melanoma. (Source: Medscape Oncology)
Source: Medscape Oncology - February 22, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Hydrochlorothiazide and Skin Cancer: Should We Be Worried?
Should we be concerned about, or take any action on, a new link found between this common antihypertensive agent and skin cancer? (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - January 12, 2018 Category: General Medicine Authors: Medscape Source Type: podcasts
Who visits raccoon latrines, and boosting cancer therapy with gut microbes
David Grimm —online news editor for Science—talks with Sarah Crespi about a long-term project monitoring raccoon latrines in California. What influence do these wild bathrooms have on the ecosystem?
Sarah also interviews Christian Jobin of the University of Florida in Gainesville about his Perspective on t hree papers linking the success of cancer immunotherapy with microbes in the gut—it turns out which bacteria live in a cancer patient’s intestines can predict their response to this cutting-edge cancer treatment.
Read the related papers:
Routy et al., Gut microbiome influences efficacy of PD- 1–based immuno...
Source: Science Magazine Podcast - January 4, 2018 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts
Who visits raccoon latrines, and boosting cancer therapy with gut microbes
David Grimm—online news editor for Science—talks with Sarah Crespi about a long-term project monitoring raccoon latrines in California. What influence do these wild bathrooms have on the ecosystem?
Sarah also interviews Christian Jobin of the University of Florida in Gainesville about his Perspective on three papers linking the success of cancer immunotherapy with microbes in the gut—it turns out which bacteria live in a cancer patient’s intestines can predict their response to this cutting-edge cancer treatment.
Read the related papers:
Routy et al., Gut microbiome influences efficacy of PD-1–based imm...
Source: Science Magazine Podcast - January 4, 2018 Category: Science Authors: Science Magazine Source Type: podcasts
Who visits raccoon latrines, and boosting cancer therapy with gut microbes
David Grimm —online news editor for Science—talks with Sarah Crespi about a long-term project monitoring raccoon latrines in California. What influence do these wild bathrooms have on the ecosystem?
Sarah also interviews Christian Jobin of the University of Florida in Gainesville about his Perspective on t hree papers linking the success of cancer immunotherapy with microbes in the gut—it turns out which bacteria live in a cancer patient’s intestines can predict their response to this cutting edge cancer treatment.
Read the related papers:
Routy et al., Gut microbiome influences efficacy of PD- 1–based immuno...
Source: Science Magazine Podcast - January 4, 2018 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts
